Pharmacy Times
JUNE 23, 2022
But investigators find that individuals who had shingles that spread to the central nervous system had nearly twice the risk of developing mental deterioration, though it is rare.
pharmaphorum
JUNE 23, 2022
Eisai’s digital tool to allow self-assessment of cognitive performance – NouKNOW – will be used in a Japanese project aimed at improving the management of dementia. The smartphone app – which uses a cognition-checking algorithm developed by Australian digital health company Cogstate – will be deployed in Bunkyo City, Tokyo in a dementia monitoring programme.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 23, 2022
Insurers are refusing to cover new, highly effective anti-obesity drugs, but some prescribers are getting around the issue.
PharmaVoice
JUNE 23, 2022
The company’s CEO explains how its Prix Galien award-winning app bridges patient care, treatment support and clinical research.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JUNE 23, 2022
The Opioid and Naloxone program at North Dakota State University School of Pharmacy aims to make a difference.
Pharmaceutical Technology
JUNE 23, 2022
The European Commission (EC) has approved Novartis’ Tabrecta (capmatinib) as a monotherapy to treat advanced non-small cell lung cancer (NSCLC) in adults. The treatment is intended for patients with NSCLC harbouring alterations leading to mesenchymal-epithelial-transition factor gene (MET) exon 14 (METex14) skipping and for those who need systemic therapy after previous treatment with immunotherapy and/or platinum-based chemotherapy.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
JUNE 23, 2022
Novartis has shouldered its way into the in vivo gene editing category via a deal with US biotech Precision BioSciences, focused on a therapy for sickle cell disease (SCD). The Swiss pharma group is paying $75 million upfronting cash and equity to get the ball rolling on the collaboration, with another $1.4 billion in potential milestones if the project advances through development and onto the market.
Pharmacy Times
JUNE 23, 2022
Analysis shows that individuals who received treatment within 3 days of symptom onset with tixagevimab and cilgavimab reduced their risk by 88% compared with the placebo.
pharmaphorum
JUNE 23, 2022
Around the world, women are making important contributions to life sciences. In this series, we chart the career progression of notable women across the industry to find out what drew them to study science and how we can encourage more women to consider a role in STEM. In this edition, Giulia Guerrini, the lead pharmacist for digital pharmacy medino, discusses her journey from classics student in Italy to start-up superintendent and why it’s important to champion women in leadership positions.
Pharmacy Times
JUNE 23, 2022
Vaxneuvance was approved for an expanded indication by the FDA on June 22, 2022, for active immunization in children 6 weeks of age and older.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fossil Remedies
JUNE 23, 2022
If you see the growth pattern of the Indian economy, then it has been tremendous. The country has done remarkably well and despite the setback after the pandemic, it is roaring high with full speed. All sector of the Indian economy has done good, but the pharma sector is doing exceptionally well. It is among the fastest-growing sectors in India. Since there is an opportunity to earn, every dynamic business owner wants to reap benefits from that.
Pharmacy Times
JUNE 23, 2022
This year's theme "Team Up!" encourages pharmacists and their teams to meet in-person at the NCPA Annual Convention.
Pharmaceutical Technology
JUNE 23, 2022
In the last year, well-known contract manufacturing organisations (CMOs) such as Agilent Technologies (Santa Clara, California) and Abzena (Cambridge, UK) have expanded their continuous manufacturing capabilities. US Congress is also making substantial investments to improve the continuous manufacturing of pharmaceuticals. As more drugs are approved with continuous manufacturing, this production method is becoming increasingly mainstream.
Pharmacy Times
JUNE 23, 2022
There is a need to stop health disparities in our public health communities, especially in the LGBTQ+ space.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
JUNE 23, 2022
The US Food and Drug Administration (FDA) has granted approval for Merck's (MSD outside the US and Canada) pneumococcal 15-valent conjugate vaccine, Vaxneuvance, for use in children aged six weeks to 17 years. The vaccine is intended for active immunisation to prevent invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in people aged six weeks and above.
Pharmacy Times
JUNE 23, 2022
This month's OTC product news features contact lenses for astigmatism, supplements, and children's probiotics.
Pharmaceutical Technology
JUNE 23, 2022
As recent changes to the price setting of drugs have improved the market access risk environment in France, GlobalData looks at their impact on the pricing of orphan drugs. Changes to price negotiations positive for orphan drugs. The changes in question were introduced via the new contractual agreement signed by the French Pharmaceutical Companies Association (LEEM) and the Ministry of Health’s (MoH’s) Economic Committee for Health Products (CEPS) in March 2021.
Pharmacy Times
JUNE 23, 2022
Simplifying processes reduces errors in compounding, IV pump programming, and physician order entry.
Viseven
JUNE 23, 2022
The faster digitalization goes worldwide, the more pharma companies find out about new tools and approaches for digital self-promotion. Digitalization brought new challenges to any industry related to online activities and social influence. Pharma and the specialties of pharma’s marketing appeared to be under influence as well. Modern days marketers are as good as quickly they adapt and overcome today’s challenges.
Pharmacy Times
JUNE 23, 2022
In clinical trials, dabrafenib and trametinib showed meaningful efficacy in multiple BRAF-positive tumor types, including in patients with rare cancers who have no other treatment options available.
Digital Pharmacist
JUNE 23, 2022
Summer is a great time to educate your community about different health topics that arise more frequently this time of year at your pharmacy. We’ve compiled a few topics within this blog post to help you ensure your patients have a healthy and safe summer season. Summer Travel Vaccinations. With lessening travel restrictions following the peak of the pandemic, it is estimated that travel plans will be increasing this summer.
Pharmacy Times
JUNE 23, 2022
Acuvail ophthalmic solution is a nonsteroidal, anti-inflammatory indicated for the treatment of pain and inflammation following cataract surgery.
PharmaVoice
JUNE 23, 2022
Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.
Pharmaceutical Technology
JUNE 23, 2022
The metaverse will make digital media experiences more immersive, inclusive, and accessible than today. However, it will raise social concerns ranging from data privacy to other forms of online harm. Listed below are the key regulatory trends impacting the metaverse theme, as identified by GlobalData. Net neutrality. Net neutrality refers to the concept that a telecom network should be a neutral gateway to the Internet rather than a gatekeeper with the power to decide what content is available o
pharmaphorum
JUNE 23, 2022
US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant. The suit – filed in a Massachusetts district court – claims that Paxlovid (nirmatrelvir and ritonavir) infringes its 11,358,953 patent which covers “compounds and pharmaceutically acceptable salts which inhibit coronavirus replication activity, and methods of treating a coronavirus infection” and wa
Pharmaceutical Technology
JUNE 23, 2022
Researchers at the University of New Hampshire (UNH) have found that a repurposed drug, CCG-50014, could hinder the activity of a key enzyme of the SARS-CoV-2 virus, which causes Covid-19. Utilising a currently available drug compound in a new way is called drug repurposing. The main protease enzyme Mpro, a key enzyme related to Covid-19, was the key target of the team in the study.
pharmaphorum
JUNE 23, 2022
Novartis’ two-drug regimen of Tafinlar and Mekinist has been approved by the FDA as the first therapy for solid tumours that have a BRAF V600E mutation – regardless of where they occur in the body. The so-called “tumour-agnostic” indication for BRAF inhibitor Tafinlar (dabrafenib) and MEK inhibitor Mekinist (trametinib) covers patients aged six and over with tumours that have progressed after earlier treatment and have no alternative therapies available.
Pharmaceutical Technology
JUNE 23, 2022
Gaming and social media companies are at the vanguard of metaverse development, but enterprises will lead the charge in the next three years. This shift will be driven by the future of work and digital transformation initiatives ongoing across sectors ranging from retail to healthcare and financial services. Big Tech is championing the metaverse, with Microsoft and Meta promoting it as the ideal environment to support hybrid working.
PharmExec
JUNE 23, 2022
In episode 111, Kevin Ali, CEO of Organon, talks about how’s he’s lead the launch of a new niche company for women’s health, and what he hopes it can achieve.
Pharmaceutical Technology
JUNE 23, 2022
The global healthcare and pharmaceutical industry is frequently faced with having to find new ways of innovating and carrying out its work in order to overcome tragic circumstances that will typically come with a huge human cost. During the peak of the Covid-19 pandemic this challenge reached new heights, as pharmaceutical firms around the world mobilised the full might of their resources to try and identify, develop, and trial a wide range of vaccines and therapeutics to alleviate the lethal th
Outsourcing Pharma
JUNE 23, 2022
The trial financial management company outlined a range of solutions designed to help trial teams get a handle on budgeting, patient reimbursement, and more.
Pharmaceutical Technology
JUNE 23, 2022
The proportion of pharmaceutical companies hiring for robotics related positions rose in May 2022 compared with the equivalent month last year, with 20.8% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 19.7% of companies who were hiring for robotics related jobs a year ago but a decrease compared to the figure of 21.8% in April 2022.
Outsourcing Pharma
JUNE 23, 2022
The 32nd iteration of the companyâs Beyond Borders report offers an in-depth look at the state of the current market landscape, and whatâs on the horizon.
Pharmacy Times
JUNE 23, 2022
Arthriten may offer relief from minor arthritis pain.
Expert insights. Personalized for you.
139 
Let's personalize your content